Latest in Stocks Term
Sort by
84 items
-
Jim Cramer's top 10 things to watch in the stock market Wednesday
Eli Lilly crushed Novo Nordisk's in a head-to-head obesity drug trial. Salesforce and Marvell shares surged on earnings.CNBC - 5h -
Salesforce earnings spur a big stock rally. Is the AI hype justified?
Wall Street seems excited about early momentum for Salesforce’s Agentforce AI product, but some analysts are skeptical about the monetization potential.MarketWatch - 4h -
How 20 big U.S. stocks are expected to rank as ‘cash machines’ in 2025
Among the Magnificent Seven, Alphabet is expected to have the highest free cash flow yield.MarketWatch - 4h -
Marvell’s stock skyrockets as it’s dubbed the next hot AI chip name
Wall Street is excited about Marvell’s traction in custom offerings and partnership with Amazon’s AWS.MarketWatch - 3h -
Tech stocks hit first all-time high since July
Technology stocks powered to new highs on Wednesday as the tech-heavy Nasdaq Composite rallied 1% and investors poured into key software and megacap players.CNBC - 30m -
Chipmaker Marvell's strong quarter is good news for these 3 portfolio stocks
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.CNBC - 2h -
Terns’s stock soars as analysts cheer leukemia data — and predict more gains
The pharma company now has two positive proof-of-concept trials under its belt, including its weight-loss pill.MarketWatch - 1h -
We're downgrading a stock on tariff risk — plus, chips and software plays stand out
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - 40m -
Tesla’s stock surges after self-driving software update, new Street-high target
Tesla’s stock jumps toward a 2 1/2-year high after the EV-maker’s FSD software gets its awaited update.MarketWatch - 2d -
Cramer calls Disney stock a 'great bargain' as CEO Bob Iger scores another big box office win
Disney broke some more box office records with 'Moana 2' over the long Thanksgiving weekend.CNBC - 1d -
Art Cashin, New York Stock Exchange fixture for decades, dies at age 83
Art Cashin was UBS' director of floor operations at the NYSE and a man The Washington Post called "Wall Street's version of Walter Cronkite."CNBC - 1d -
Zscaler’s post-earnings stock drop further bucks 2024’s rally by software sector
Zscaler’s stock was down on the year prior to earnings, while an ETF tracking the software sector had rallied 29%MarketWatch - 1d -
Asian chip stocks mostly rise, shrugging off new U.S. semiconductor export curbs on China
Shares of major Asian chip stocks mostly rose on Tuesday, shrugging off the U.S. announcing new emiconductor export controls on China.CNBC - 1d -
Top tech stocks are ‘cash machines,’ so keep buying, says the dean of valuation
Aswath Damodaran, the NYU Stern School of Business finance professor, says big tech stocks are “insanely profitable,” and should be bought in case of pullbacks.MarketWatch - 1d -
‘Contrarians aren’t being rewarded,’ and short sellers of U.S. stocks are giving up, says Citigroup
Strategists at Citigroup say investors are increasingly giving up on bets against the U.S. stock market.MarketWatch - 1d -
Donald Trump Jr. joins PSQ Holdings' board, sending shares skyrocketing 270%
PSQ is a microcap stock with a market capitalization of only $72 million as of Monday's close.CNBC - 23h -
Salesforce surges on revenue beat, AI growth prospects – here's our new price target for the stock
Salesforce made clear that Agentfoce, its new AI offering, can kickstart revenue growth in the quarters ahead.CNBC - 19h -
Wall Street expects the stock rally to keep ripping through New Year’s Eve. But watch these risks.
The S&P 500 just capped off its best month in a year, and is on track to rise nearly 30% in 2024.MarketWatch - 9h -
Stocks and bonds haven’t moved together like this in three decades – and that’s putting portfolios at risk, says State Street
A so-called balanced portfolio is anything but given the correlation of stock and bond returns as well as concentration in stocks.MarketWatch - 5h -
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy
Zepbound helped patients lose more weight than a major rival in a head-to-head trial.MarketWatch - 4h -
These stocks aren’t likely to beat the S&P 500 next year — for this one reason
Difficult-to-short stocks often trade at artificially inflated, unsustainable prices.MarketWatch - 26m -
Why this star trader is ‘HODL-ing’ bitcoin, small-caps and short-squeeze stocks for now
Robert Ross: ‘If a stock is not going up in a bull market like this, it’s not something I want to own.’MarketWatch - 40m -
JetBlue offers fresh sign of strong travel demand, sending its stock higher
JetBlue raises its guidance to reflect higher-than-expected bookings in November and December.MarketWatch - 7h -
South Korea's short-lived martial law declaration rattled markets. Here's what's next for stocks
An extraordinary political drama in South Korea is likely to compound an already gloomy outlook for Asia's fourth-largest economy, analysts say.CNBC - 4h -
Here’s what’s clicking now for Dollar Tree after a tough year for its stock
Retailer opens 249 new stores, books a 1.5% increase in traffic and says its Family Dollar review is on track.MarketWatch - 6h